See also this year's filing and all EDGAR filings for this company.
PDF Report 0001629137_2021_Global_Blood_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001629137, Global Blood Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 632,163,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 37,882,000 |
| 3 | remainder_Assets | 53,957,000 |
| 4 | LiabilitiesCurrent | 79,032,000 |
| 5 | LiabilitiesNoncurrent | 228,813,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,986,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 210,851,000 |
| 9 | ResearchAndDevelopmentExpense | 155,122,000 |
| 10 | remainder_Expenses | -984,000 |
| 11 | remainder_Revenues | 123,803,000 |
| 12 | remainder_NetIncome | -4,381,000 |
| 13 | remainder_ComprehensiveNetIncome | -452,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 724,002,000 |
| 1 | Liabilities | 307,845,000 |
| 2 | Expenses | 366,975,000 |
| 3 | Revenues | 123,803,000 |
| 4 | StockholdersEquity | 416,157,000 |
| 5 | NetIncome | -247,553,000 |
| 6 | ComprehensiveNetIncome | -247,779,000 |
| 7 | BaseVar | 763,729,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.28 |
| 9 | EconomicCapitalRatio | 2.52 |
Edgar->Model Mapping
Feature Distribution
Change over Time
